The AI trade lost momentum into the close — equities finished narrowly higher but below the records they touched intraday · Iran suspends nuclear talks with Washington as Israel threatens Beirut, keeping a bid under oil · Alphabet to sell up to $80bn in shares to fund its AI build-out, with Berkshire anchoring a $10bn private placement · Russia finance officials reportedly warn Putin the war is unaffordable.
Europe/Rome 06:00 · Markets open · pre-US-open · Range-bound · AI momentum cooling
Levels below are the Bloomberg Europe live ticker read at ~06:00 Rome. US indices reflect Monday’s close — the session when stocks slipped from a record as the AI trade lost steam — while FTSE, FX and commodities are live. The week’s decisive data lands later: euro-area releases midweek and US May payrolls on Friday, with the ECB decision on 11 June now the next big rates event.
Top of the morning
Iran suspends talks with Washington as Israel threatens Beirut
Tehran reportedly halted negotiations with the US after Israel signalled it could strike a Hezbollah stronghold in the Lebanese capital. Trump and Netanyahu gave conflicting accounts of a tense call: the White House pressed Israel to scale back its Lebanon push and said its forces would not move on Beirut, while Netanyahu insisted strikes on the south would continue. Hezbollah is said to have accepted a US-brokered mutual cease-fire; Trump told one network he believes a Hormuz-reopening and truce extension is still reachable “within a week.” Crude held its gains (~+0.9%).
The AI trade loses momentum, pulling stocks off their highs
Bloomberg’s lead market story: equities slipped from a record as the AI rally lost steam, even though the tape closed marginally green (S&P +0.26%, Nasdaq +0.42%). The wobble lands amid a noisy valuation debate — FT reports Wall Street bulls still betting the rally defies bubble fears, against a Ruchir Sharma column arguing the US “profit machine” is no stronger than during the dotcom boom.
Alphabet to raise up to $80bn for AI — Berkshire anchors $10bn
Alphabet plans to sell up to $80bn in equity to fund its AI build-out, with the raise including a $10bn private placement to Berkshire Hathaway. It is a striking double signal for your book: the scale of the capex financing, and Buffett/Abel’s Berkshire stepping directly into a marquee AI-infrastructure name rather than its usual value fare.
Nvidia pushes into PCs as Intel readies an inference challenger
Nvidia is entering the laptop market with a new “superchip,” taking on Intel and AMD, and gave Arm a lift at Computex; its chief said staff should be paid “as much as possible.” Meanwhile Intel says it will target Nvidia directly with an inference GPU by year-end — its shares are up more than 200% this year. The chip cycle stays the market’s central battleground.
Russia: officials warn Putin the war is unaffordable
A Bloomberg exclusive reports finance officials have told Putin that war spending is no longer sustainable, even as Moscow banned jet-fuel exports following record drone strikes on its refineries. In parallel, Germany’s Merz is set to convene European leaders to reshape NATO in a bid to keep Washington engaged — the fiscal and alliance strains are converging.
Anthropic files confidentially for an IPO
The maker of the Claude chatbot has filed confidentially to go public, edging ahead of OpenAI in the race to market. Reporting puts its latest private valuation near $900bn–$965bn after a ~$65bn round last week. Alphabet’s parallel $80bn equity raise underscores how much capital the AI build-out is now absorbing.
Health watch: Congo’s Ebola fight digs in; UK cancer care still “fragile”
Congo has reopened the main airport in the Ebola epicentre as officials brace for a prolonged outbreak, with commentary urging an Africa-led response. Separately, FT reports UK cancer services remain “fragile” after the pandemic — more than one in five cases were missed during lockdowns — and Sandoz warns cheap imports threaten Europe’s antibiotic supply. Quiet but consequential reading for the clinic.
FT portfolio signal · tied to your holdings
What FT flagged for your book
Macro / regime read. The dominant thread this morning is the valuation/bubble debate, not a fresh shock. myFT instant alerts cluster around it: bulls betting the AI rally defies bubble fears, Ruchir Sharma arguing US profitability is no better than the dotcom peak, and SoftBank overtaking Toyota as Japan’s largest company on AI demand — all against Bloomberg’s “AI trade loses momentum” lead. Underneath sits a rising-rates backdrop: the US 10-year is firm near 4.44%, global yields are grinding higher, and the ECB’s 11 June decision is live with a hike not ruled out. The lone credit-stress flag carried over from yesterday — private-credit outflows as retail eyes the exits — is a watch item, not a severe trigger; the dashboard’s war-chest rules stay dormant.
Alphabet (shelf single-name hit). The up-to-$80bn equity raise is sizeable dilution but funds the AI capex that underpins the thesis; the $10bn Berkshire private placement is an unusual external vote of confidence. Net read-through: capex conviction intact, with a marquee validator attached.
Berkshire / Buffett (shelf single-name hit ×2). Two deployments at once — the $10bn Alphabet placement and last weekend’s $8.5bn purchase of homebuilder Taylor Morrison, Abel’s first big deal. Signal: the new CEO is putting the cash pile to work across both AI infrastructure and a cyclical housing-recovery bet.
Semiconductors / AI capex (theme hits). Nvidia’s PC push, Intel’s planned inference GPU, and an Unhedged piece on AI’s GDP impact and the chip cycle all reinforce the picks-and-shovels case behind your ASML, Broadcom, Microsoft/Azure, Alphabet shelf. The cooling-momentum and dotcom-comparison framing is the risk to respect.
Pharma colour (no single-name hit). myFT pharma alerts skewed to Roche’s oncology reinvention, Western reliance on Chinese biotechs, and Europe’s antibiotic-supply risk — sector and supply-chain context, no direct read on Novo, Lilly, Vertex, UnitedHealth, Thermo Fisher or Intuitive.
Shelf single-names: today’s live alerts are Alphabet and Berkshire. No GLP-1 / Novo Nordisk / Eli Lilly / Vertex / UnitedHealth / Intuitive / Visa / Mastercard single-name FT items in the window. (Name-level alerts only surface here once FT routes them to this Gmail — see the iCloud→Gmail forwarding note if they stay sparse.)
Net: AI-capex tailwind intact but momentum is cooling and the valuation debate is loud; Berkshire’s twin deals show genuine cash deployment. Regime = watch, not deploy. Friday’s US payrolls and the 11 June ECB are the swing events.
Markets snapshot
Bloomberg Europe live ticker at ~06:00 Rome. US indices are Monday’s close (the slip-from-record session); FTSE, FX and commodities live. Daily % changes as shown on the ticker.
Instrument
Last
Change / context
S&P 500
7,599.96
+0.26% · closed below intraday record
Nasdaq
27,086.81
+0.42% · AI leadership cooling
Bloomberg 500
2,748.42
+0.31%
FTSE 100
10,338.95
+0.68%
US 10-year Treasury
4.44%
yields firm · global rates grinding higher
EUR/USD
~1.16
+0.03% · little changed
GBP/USD
~1.35
+0.04%
Crude (WTI)
$91.32
+0.91% · Iran/Lebanon premium holds
Gold (spot)
$4,527.90
+0.48% · geopolitical hedge bid
Figures transcribed from the Bloomberg Europe “Top Securities” ticker; FX shown to two decimals as on the ticker.
Global markets & macro
The tone has shifted from chase-the-record to consolidation. Equities closed narrowly higher but below the highs they touched, as Bloomberg’s lead framed an AI trade that is losing momentum after months of leadership. The backdrop is a louder valuation argument: FT carries Wall Street bulls still betting the rally outruns bubble fears, set against a column warning that US corporate profitability is no stronger than at the dotcom peak. SoftBank overtaking Toyota as Japan’s most valuable company captures the same AI-concentration theme from the other side. The single biggest capital signal is Alphabet’s plan to raise up to $80bn in equity to fund its build-out — with Berkshire taking a $10bn slice — a reminder of how much funding the AI cycle is now absorbing.
Rates are the quieter but firmer sub-plot. The US 10-year sits near 4.44% with global yields grinding higher, and the ECB’s 11 June meeting is live — policymakers have signalled the decision is data-dependent and a hike is not off the table. Asia gave mixed cues overnight: Japan’s 10-year yield fell after an auction drew firm demand, while the PBOC cut its cash operation to a record low as a bond rally deepened and Chinese LNG imports rebounded into summer. Beneath the index calm, the cautionary note that lingers is private-credit turmoil nudging retail investors toward the exits. The data that matters arrives later this week — euro-area releases midweek and Friday’s US payrolls — just as oil threatens to keep the energy component of inflation warm.
Geopolitics & world news
The US–Iran track has stalled and turned tense. Tehran reportedly suspended negotiations after Israel signalled it could strike a Hezbollah stronghold in Beirut, and Trump and Netanyahu offered conflicting accounts of a heated call — Washington pressing Israel to pull back and stating its forces would not move on the capital, Netanyahu vowing to keep striking southern Lebanon. Hezbollah is said to have accepted a US proposal for a mutual halt in attacks, and Trump publicly insists a deal to reopen the Strait of Hormuz and extend the cease-fire is reachable within a week — even as he played down the stakes in one interview. Markets read it simply: oil stays bid (WTI ~$91) and gold holds its hedge premium.
Two further threads. In Russia, a Bloomberg exclusive says finance officials have warned Putin that war spending is unaffordable, while Moscow banned jet-fuel exports after record refinery strikes — and Germany’s Merz prepares to gather European leaders to reshape NATO around keeping Trump engaged. In Europe, Denmark’s Mette Frederiksen won a third term after record-long coalition talks, and the EU is poised to give members budget leeway to cushion energy costs while trying to keep an oil windfall out of Russia’s hands. For the medical reader, the standout items are clinical as much as geopolitical: Congo’s reopened airport and the brace for a long Ebola fight, the UK’s pandemic-strained cancer services, and Europe’s antibiotic-supply vulnerability — each a quiet signal for the drug-development and public-health landscape.
Today & week ahead (CET)
Mon 1Global manufacturing PMIs & US ISM — first read on June momentum (now in the rear-view)
Tue 2Euro-area data · watch for any Iran–Lebanon cease-fire confirmation · Anthropic IPO follow-through · Alphabet raise details
Wed 3US ISM services & ADP private payrolls · China Caixin services PMI — the payrolls warm-up
Thu 4US weekly jobless claims · ECB speakers into the blackout · euro-area PPI
Fri 5US May jobs report — payrolls and unemployment, the week’s marquee print for the Fed-path debate
Wed 11ECB rate decision — data-dependent; a hike is not ruled out (next week)
WatchAI-trade momentum & the bubble debate · oil on Iran–Lebanon headlines · private-credit stress · Alphabet/Berkshire capital moves · Russia war-fiscal strain